Preparation of long-acting microspheres loaded with octreotide for the treatment of portal hypertensive
Authors:
Open Access
- 1 January 2021
- journal article
- research article
- Published by Taylor & Francis in Drug Delivery
- Vol. 28 (1) , 719-732
Abstract
The purpose of this study was to optimize the preparation method of injectable Octreotide microspheres. To explore the correlation between the solvent system and the general properties of microspheres to reduce burst release and enable them to be used for portal hypertension. Octreotide microspheres were prepared by modified double emulsion solution evaporation method after optimizing preparation conditions. The results showed that Octreotide microspheres had a particle size of 57.48 ± 15.24 μm, and the initial release was significantly reduced. In vitro release and in vivo pharmacokinetic data indicated that Octreotide was released stably within 1200 h. The effects on portal vein pressure, liver tissue morphology and other related indexes were observed after administration. As obvious results, injection of Octreotide microspheres could significantly reduce portal vein pressure and reduce the portal vein lumen area in experimental cirrhotic portal hypertensive rats. The optimized Octreotide PLGA microsphere preparation has been proved to have a good effect on PHT in vivo after detecting aminotransferase (AST) and alanine aminotransferase (ALT) activity, liver tissue hydroxyproline (Hyp) content, serum and liver tissue malondialdehyde (MDA) levels, plasma prostacyclin (PGI2) levels, and liver tissue tumor necrosis factor (TNFα) content. In addition, serum and liver tissue superoxide dismutase (SOD) activity and liver tissue glutathione (GSH) content, plasma thromboxane (TXA2), serum nitric oxide (NO), liver tissue nitric oxide synthase (NOS), and plasma and liver tissue endothelin (ET) were significantly increased.Keywords
Funding Information
- Science and Technology Development Project form Jilin Science and Technology Department (20130727054YY, 20160209013YY, 20180311072YY)
- Jilin Province Development and Reform Commission (2014N149)
This publication has 32 references indexed in Scilit:
- Meta‐analysis: vasoactive medications for the management of acute variceal bleedsAlimentary Pharmacology & Therapeutics, 2012
- Sustained-Release Delivery of Octreotide from Biodegradable Polymeric MicrospheresAAPS PharmSciTech, 2011
- Effect of bases with different solubility on the release behavior of risperidone loaded PLGA microspheresColloids and Surfaces B: Biointerfaces, 2011
- Controlled Release of Octreotide and Assessment of Peptide Acylation from Poly(D,L-lactide-co-hydroxymethyl glycolide) Compared to PLGA MicrospheresPharmaceutical Research, 2011
- Preparation of Bleomycin A2–PLGA Microspheres and Related In Vitro and In Vivo StudiesJournal of Pharmaceutical Sciences, 2011
- Preparation of pingyangmycin PLGA microspheres and related in vitro/in vivo studiesInternational Journal of Pharmaceutics, 2010
- The somatostatin analogue octreotide inhibits angiogenesis in the earliest, but not in advanced, stages of portal hypertension in ratsJournal of Cellular and Molecular Medicine, 2008
- Controlled drug release from a novel injectable biodegradable microsphere/scaffold composite based on poly(propylene fumarate)Journal of Biomedical Materials Research Part A, 2006
- Preparation and Characterization of Poly(D,L-Lactic-Co-Glycolic Acid) Microspheres Containing Flurbiprofen SodiumDrug Delivery, 2006
- Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation methodBiomaterials, 2001